Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer
NCT03936205
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Refractory Pain
Metastatic Cancer
Interventions
DRUG:
Dexmedetomidine
Sponsor
Hotel Dieu de France Hospital